Source: China – South China Morning PostThe Covid-19 vaccine developed by Chinese company Sinovac is safe and effective for children as young as three, early stage human trials have found, as China seeks to expand immunisation coverage.The vaccine, which gained World Health Organization emergency use approval for adults earlier this month, has already been approved for emergency use for children above three years old and teenagers in China – although authorities have not announced an immunisation schedule for these groups.Sinovac is…Read More